Inflammation is a risk factor for some cancers, and polymorphisms in Nod2 are associated with increased risk for colorectal cancer19–21 and may be associated with increased risk for lymphoma, gastric, breast, ovarian, lung, and laryngeal cancers21. The gene discussed is NOD2; the disease is cancer.